Filtered By:
Specialty: Cancer & Oncology
Condition: Hemorrhagic Stroke

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 62 results found since Jan 2013.

Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial
This study has been approved by the National Ethics Committee (IDRCB:2019-A01543-54/SI:19.06.21.40640). ClinicalTrials.gov NCT04053166.PMID:35164816 | DOI:10.1186/s13063-022-06061-x
Source: Cancer Control - February 15, 2022 Category: Cancer & Oncology Authors: Mathilde Mura Emeraude Rivoire Leila Dehina-Khenniche Mich èle Weiss-Gayet B énédicte Chazaud Camille Faes Philippe Connes Anne Long Chantal L Rytz Pauline Mury Lidia Delrieu Etienne Gouraud Marine Bordet Nellie Della Schiava Patrick Lermusiaux Matthie Source Type: research

Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis
ConclusionsStroke incidence is significantly increased after diagnosis of certain cancers.Implications for Cancer SurvivorsCardiovascular risk should be assessed during cancer survivorship care, with attention to modifying shared cancer/cardiovascular risk factors.
Source: Journal of Cancer Survivorship - November 5, 2021 Category: Cancer & Oncology Source Type: research

Association of physical activity with stroke among long-term colorectal cancer survivors
ConclusionsModerate frequency of moderate-to-vigorous physical activity (5-9 time/week) and walking (4-5 time/week) significantly lowers the risk of stroke, whereas high-frequency physical activity reduces the benefits of physical activity.Implications for Cancer SurvivorsPhysical activity with moderate frequency is important in the prevention of stroke for long-term colorectal cancer survivors.
Source: Journal of Cancer Survivorship - June 17, 2021 Category: Cancer & Oncology Source Type: research

Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?
ConclusionAC did not seem to influence the incidence of ICH in patients with glioblastoma or brain metastases within follow up of just under 9  months.
Source: Journal of Neuro-Oncology - March 5, 2021 Category: Cancer & Oncology Source Type: research

Novel Oral Anticoagulant versus Warfarin in Cancer Patients with Atrial Fibrillation: An 8-Year Population-Based Cohort Study
Conclusion: In cancer patients with AF, NOAC were associated with significant reduced IS/SE, major bleeding, and ICH compared to warfarin.
Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Victor Chien-Chia Wu, Chun-Li Wang, Yu-Tung Huang, Wen-Ching Lan, Michael Wu, Chang-Fu Kuo, Shao-Wei Chen, Pao-Hsien Chu, Ming-Shien Wen, Chi-Ching Kuo, Shang-Hung Chang Tags: Research Paper Source Type: research

A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding.
CONCLUSION: Although these agents have been marketed for five years (idarucizumab) and two years (andexanet alfa) respectively, and despite guidelines considering antidotes as first-line agents in treating life-threatening hemorrhage when available, these antidotes seem to gain access very slowly in the clinical practice. Cost, logistical aspects and need for plasma level determination of DOAC for an accurate therapeutic use probably have an impact on this phenomenon.. An expert multidisciplinary bleeding team should be established so as to implement international guidelines based on local resources and organization. ...
Source: Reviews on Recent Clinical Trials - June 23, 2020 Category: Cancer & Oncology Authors: Ojetti V, Saviano A, Brigida M, Saviano L, Migneco A, Franceschi F Tags: Rev Recent Clin Trials Source Type: research

Infections Tied to Subsequent Risk for Acute Ischemic Stroke
Correlation highest for UTI; smaller - magnitude associations seen for UTI with intracerebral hemorrhage
Source: The Doctors Lounge - Oncology - June 28, 2019 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Oncology, Urology, Journal, Source Type: news

Platelet count is associated with outcome in cancer patients with stroke
ConclusionIn cancer patients with CVD, thrombocytopenia at the time of CVD diagnosis and altered mental status during initial clinical evaluation were associated with higher mortality, which should be confirmed in future studies.
Source: Journal of Neuro-Oncology - November 28, 2018 Category: Cancer & Oncology Source Type: research

Clinical significances and features of prompt brain CT scan after intracranial artery stenting: analysis of 501 cases.
Authors: Li J, Cheng SY, Xiong XY, Duan CM, Liu L, Zhou Y, Zhang JR, Wang L, Zhou K, Gong ZL, Liu Y, Wei F, Shuai J, Shen L, Yang QW Abstract Cerebral hemorrhage is a serious complication of intracranial artery stenting that could be fatal without timely identification and treatment. Prompt brain CT scan would help to evaluate whether cerebral hemorrhage occurs, however, the diverse features of the CT scan immediately after stenting could influence the judgement sometimes. Therefore, we analyzed and summarized these features to help to determine the clinical significance of these CT features. The prompt CT features...
Source: Oncotarget - January 28, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research

Predictors of unknown cancer in patients with ischemic stroke
AbstractStroke is the second most frequent neurologic finding in postmortem studies of cancer patients. It has also been described as the first expression of an occult cancer. We have studied patients diagnosed with cancer after an ischemic stroke (IS) and we analyze differences with non-tumor patients. Single cohort longitudinal retrospective study of patients admitted to our center with IS diagnosis from 1 January 2012 to 12 December 2014. All patients were followed for 18  months. Patients with transient ischemic infarction or cerebral hemorrhage, active cancer or in the last 5 years, inability to follow-up or absence...
Source: Journal of Neuro-Oncology - January 8, 2018 Category: Cancer & Oncology Source Type: research

Predictors of hematoma expansion predictors after intracerebral hemorrhage.
Authors: Chen S, Zhao B, Wang W, Shi L, Reis C, Zhang J Abstract Despite years of effort, intracerebral hemorrhage (ICH) remains the most devastating form of stroke with more than 40% 30-day mortality worldwide. Hematoma expansion (HE), which occurs in one third of ICH patients, is strongly predictive of worse prognosis and potentially preventable if high-risk patients were identified in the early phase of ICH. In this review, we summarize data from recent studies on HE prediction and classify those potential indicators into four categories: clinical (severity of consciousness disturbance; blood pressure; blood glu...
Source: Oncotarget - November 29, 2017 Category: Cancer & Oncology Tags: Oncotarget Source Type: research

The Epidemiology and Clinical Associations of Stroke in Patients with Acute Myeloid Leukemia: A review of 10,972 admissions from the 2012 National Inpatient Sample
Conclusions Patients with AML have an elevated risk of CVA compared to all inpatients and mortality in this population is high. Better characterization of risk factors of stroke in this vulnerable population is still needed. Teaser Acute leukemia predisposes patients toward the development of stroke. The latter, while devastating clinically, has been infrequently studied. Our study, using the 2012 National Inpatient Sample, found a 50-fold increase in the risk of stroke as compared to all inpatient admissions with a corresponding 5.5-fold increased risk of mortality. Significant risk factors for the development of stroke i...
Source: Clinical Lymphoma Myeloma and Leukemia - September 21, 2017 Category: Cancer & Oncology Source Type: research

Radioiodine Therapy for Thyroid Cancer Doesn ’ t Up Stroke Risk
I - 131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke
Source: The Doctors Lounge - Oncology - August 19, 2017 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Neurology, Oncology, ENT, Radiology, Journal, Source Type: news

Circulating long-chain n-3 polyunsaturated fatty acid and incidence of stroke: a meta-analysis of prospective cohort studies.
CONCLUSIONS: Circulating LC n-3 PUFAs were linearly associated with reduced risk of stroke, especially 22:5n-3 and 22:6n-3. Such findings highlight the importance of circulating LC n-3 PUFA in the development of ischemic stroke. PMID: 28767407 [PubMed - as supplied by publisher]
Source: Oncotarget - August 4, 2017 Category: Cancer & Oncology Tags: Oncotarget Source Type: research

Predictors of hematoma expansion predictors after intracerebral hemorrhage.
Authors: Chen S, Zhao B, Wang W, Shi L, Reis C, Zhang J Abstract Despite years of effort, intracerebral hemorrhage (ICH) remains the most devastating form of stroke with more than 40% 30-day mortality worldwide. Hematoma expansion (HE), which occurs in one third of ICH patients, is strongly predictive of worse prognosis and potentially preventable if high-risk patients were identified in the early phase of ICH. In this review, we summarize data from recent studies on HE prediction and classify those potential indicators into four categories: clinical (severity of consciousness disturbance; blood pressure; blood glu...
Source: Oncotarget - July 26, 2017 Category: Cancer & Oncology Tags: Oncotarget Source Type: research